Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Pharmacological and anatomical evidence suggests that abnormal glutamate neurotransmission may be associated with the pathophysiology of schizophrenia and mood disorders. Medial temporal lobe structural alterations have been implicated in schizophrenia and to a lesser extent in mood disorders. To comprehensively examine the ionotropic glutamate receptors in these illnesses, we used in situ hybridization to determine transcript expression of N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and kainate receptor subunits in the medial temporal lobe of subjects with schizophrenia, bipolar disorder (BD), or major depression (MDD). We used receptor autoradiography to assess changes in glutamate receptor binding in the same subjects. Our results indicate that there are region- and disorder-specific abnormalities in the expression of ionotropic glutamate receptor subunits in schizophrenia and mood disorders. We did not find any changes in transcript expression in the hippocampus. In the entorhinal cortex, most changes in glutamate receptor expression were associated with BD, with decreased GluR2, GluR3, and GluR6 mRNA expression. In the perirhinal cortex we detected decreased expression of GluR5 in all three diagnoses, of GluR1, GluR3, NR2B in both BD and MDD, and decreased NR1 and NR2A in BD and MDD, respectively. Receptor binding showed NMDA receptor subsites particularly affected in the hippocampus, where MK801 binding was reduced in schiz…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In depressed patients, synaptic plasticity pathways have been shown to be disrupted in the PFC and hippocampi, correlated with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and NMDA receptor abnormalities [45,46].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [45]
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · cited 2×
“Neurotransmission mediated by ionotropic glutamate receptors underlies several forms of synaptic plasticity in the hippocampus, including long-term potentiation (LTP) and depression (LTD) (Bliss and Collingridge, 1993; Isaac et al, 1995; Linden and Connor, 1995; Nicoll and Malenka, 1995; Selig et al, 1995; Bear and Ab…”
BackgroundLOSS OF RECENT MEMORY AFTER BILATERAL HIPPOCAMPAL LESIONS
Scoville, W. B., & Milner, B. (1957) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.20.1.11 · Cited by 7,322
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535 · cited 2×
“Scale bar: 5 mm. Neuropsychopharmacology containing predominantly NR2B to containing NR2A in response to different stimuli (Monyer et al, 1994; Sheng et al, 1994).”
BackgroundThe Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282 · cited 1×
“The entorhinal cortex is a crucial component of the medial temporal lobe memory system (Scoville and Milner, 1957; Squire and Zola-Morgan, 1991).”
BackgroundLong-Term Potentiation--A Decade of Progress?
Malenka, R. C., & Nicoll, A. R. A. (1999) · Science · doi:10.1126/science.285.5435.1870 · Cited by 2,729
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677 · cited 1×
“…in neuronal size, density, and localization in the hippocampus in schizophrenia and BD, and to a lesser extent in major depressive disorder (MDD) (Arnold, 1997; Benes et al, 1998, 1999; Harrison, 1999; Weinberger, 1999; Harrison and Eastwood, 2001; Heckers and Konradi, 2002; Rajkowska, 2002a, b).”
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,310
Cited by
Items 101–200 of 451
Reverse translational strategies for developing animal models of bipolar disorder
Malkesman, O., Austin, D. R., Chen, G., & Manji, H. K. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001628 · Cited by 70
“In addition, some human postmortem studies found reduced GRIK2 mRNA levels in the brains of individuals with BD (Benes et al., 2007; Beneyto et al., 2007).”
BackgroundGlutamate transporters: A key piece in the glutamate puzzle of major depressive disorder
Medina, A. M., Burke, S., Thompson, R. C., Bunney, W. E., Myers, R., Schatzberg, A. F., Akil, H., & Watson, S. J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.04.007 · Cited by 70
Soeiro‐de‐Souza, M. G., Salvadore, G., Moreno, R. A., Otaduy, M. C. G., Chaim, K. T., Gattaz, W. F., Zarate, C. A., & Machado‐Vieira, R. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.203 · Cited by 69
Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression
Wang, Y., Wang, X., Feng, S., Chen, N., Wang, Z., & Zhang, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105761 · Cited by 69
Sydnor, V. J., & Roalf, D. R. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.028 · Cited by 67
Bao, H., Li, H., Jia, Y., Xiao, Y., Luo, S., Zhang, D., Han, L., Dai, L., Xiao, C., Feng, L., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114561 · Cited by 67
Lee, M. T., Peng, W.-H., Kan, H.-W., Wu, C.-C., Wang, D.-W., & Ho, Y.-C. (2022) · Biomedicines · doi:10.3390/biomedicines10051005 · Cited by 65
Involvement of pGluR1, EAAT2 and EAAT3 in offspring depression induced by prenatal stress
Zhang, X., Jia, N., Zhao, X. Y., Tang, G. K., Guan, L. X., Wang, D., Sun, H., Li, H., & Zhu, Z. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.031 · Cited by 65
The first decade and beyond of transcriptional profiling in schizophrenia
Sequeira, P. A., Martin, M. V., & Vawter, M. P. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.001 · Cited by 64
Geddes, A. E., Huang, X., & Newell, K. A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.017 · Cited by 64
Vrajová, M., Šťastný, F., Horáček, J., Lochman, J., Šerý, O., Peková, Š., Klaschka, J., & Höschl, C. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0145-z · Cited by 63
Yadav, R., Hillman, B. G., Gupta, S. C., Suryavanshi, P., Bhatt, J. M., Pavuluri, R., Stairs, D. J., & Dravid, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060785 · Cited by 62
The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents
Fasipe, O. J. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.01.001 · Cited by 63
Mendez-David, I., Guilloux, J.-P., Papp, M., Tritschler, L., Mocaer, E., Gardier, A. M., Bretin, S., & David, D. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00462 · Cited by 60
High novelty-seeking rats are resilient to negative physiological effects of the early life stress
Clinton, S. M., Watson, S. J., & Akil, H. (2014) · Stress · doi:10.3109/10253890.2013.850670 · Cited by 59
Sun, X., Zhang, T., Zhao, Y. H., Cai, E., Zhu, H., & Liu, S. (2020) · Food & Function · doi:10.1039/c9fo03104a · Cited by 59
Mood-Stabilizers Target the Brain Arachidonic Acid Cascade
Rao, J. S., & Rapoport, S. I. (2009) · Current Molecular Pharmacology · doi:10.2174/1874-470210902020207 · Cited by 58
Zanetti, M. V., Otaduy, M. C. G., SOUSA, R. T. D., Gattaz, W. F., Busatto, G. F., Leite, C. C., & Machado‐Vieira, R. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu058 · Cited by 59
Soeiro‐de‐Souza, M. G., Otaduy, M. C. G., Machado‐Vieira, R., Moreno, R. A., Nery, F. G., Leite, C. D. C., & Lafer, B. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.02.007 · Cited by 59
Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders
Ghasemi, M., Phillips, C., Fahimi, A., McNerney, M. W., & Salehi, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.002 · Cited by 100
Oh-Nishi, A., Obayashi, S., Sugihara, I., Minamimoto, T., & Suhara, T. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.054 · Cited by 57
Iasevoli, F., Tomasetti, C., Buonaguro, E. F., & de Bartolomeis, A. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140324183406 · Cited by 58
Hasan, A., Mitchell, A., Schneider, A., Halene, T. B., & Akbarian, S. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0395-2 · Cited by 57
Modeling mania in preclinical settings: A comprehensive review
Sharma, A. N., Fries, G. R., Galvez, J. F., Valvassori, S. S., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.001 · Cited by 57
Ganguly, P., Holland, F. H., & Brenhouse, H. C. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.134 · Cited by 56
Specific Roles of NMDA Receptor Subunits in Mental Disorders
Yamamoto, H., Hagino, Y., Kasai, S., & Ikeda, K. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150330142807 · Cited by 56
Kristiansen, L. V., Bakir, B., Haroutunian, V., & Meador-Woodruff, J. H. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1069 · Cited by 54
Self-citationGrayson, D. R., Chen, Y., Dong, E., Kundakovic, M., & Guidotti, A. (2009) · Epigenetics · doi:10.4161/epi.4.3.8534 · Cited by 54
Li, B., Zhang, S., Zhang, H., Hertz, L., & Peng, L. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100094 · Cited by 54
Khundakar, A. A., & Thomas, A. J. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-148003 · Cited by 53
Genetic association study of individual symptoms in depression
Myung, W., Song, J., Lim, S., Won, H., Kim, S., Lee, Y., Kang, H. S., Lee, H., Kim, J., Carroll, B. J., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.037 · Cited by 53
Bloss, E. B., & Hunter, R. G. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82009-6 · Cited by 55
Sodhi, M. S., Simmons, M., McCullumsmith, R., Haroutunian, V., & Meador-Woodruff, J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.022 · Cited by 52
Self-citationSOUSA, R. T. D., Loch, A. A., Carvalho, A. F., Brunoni, A. R., Haddad, M. R., Henter, I. D., Zarate, C. A., & Machado‐Vieira, R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.149 · Cited by 52
Dean, B., Gibbons, A. S., Boer, S., Uezato, A., Meador‐Woodruff, J. H., Scarr, E., & McCullumsmith, R. E. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415586601 · Cited by 52
Self-citationRecent advances in postmortem pathology and neurochemistry in schizophrenia
Dean, B., Boer, S., Gibbons, A., Money, T., & Scarr, E. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328323d52e · Cited by 51
Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome
da Silva Alves, F., Boot, E., Schmitz, N., Nederveen, A., Vorstman, J., Lavini, C., Pouwels, P., de Haan, L., Linszen, D., & van Amelsvoort, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021685 · Cited by 51
The kinesin superfamily protein KIF17: one protein with many functions
Wong‐Riley, M. T. T., & Besharse, J. C. (2012) · BioMolecular Concepts · doi:10.1515/bmc-2011-0064 · Cited by 51
Investigational NMDA receptor modulators for depression
Szewczyk, B., Pałucha-Poniewiera, A., Poleszak, E., Pilc, A., & Nowak, G. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.638916 · Cited by 49
Wang, Q., Li, M., Yang, Z., Hu, X., Wu, H.-M., Ni, P., Ren, H., Deng, W., Li, M., Ma, X., et al. (2015) · Scientific Reports · doi:10.1038/srep18209 · Cited by 49
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Vecera, C. M., C. Courtes, A., Jones, G., Soares, J. C., & Machado-Vieira, R. (2023) · Pharmaceuticals · doi:10.3390/ph16111572 · Cited by 48
“In depressed patients, synaptic plasticity pathways have been shown to be disrupted in the PFC and hippocampi, correlated with α -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and NMDA receptor abnormalities [45,46].”
BackgroundMetabotropic glutamate receptors as emerging research targets in bipolar disorder
Blacker, C. J., Lewis, C. P., Frye, M. A., & Veldić, M. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.059 · Cited by 49
Mismatch negativity in bipolar disorder: A neurophysiological biomarker of intermediate effect?
Hermens, D. F., Chitty, K. M., & Kaur, M. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.026 · Cited by 48
Lee, H., Rao, J. S., Chang, L., Rapoport, S. I., & Bazinet, R. P. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700406-jlr200 · Cited by 47
Ketamine and suicidal ideation in depression: Jumping the gun?
Rajkumar, R., Fam, J., Yeo, E. Y. M., & Dawe, G. S. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.003 · Cited by 46
Dysregulation of glutamate carboxypeptidase II in psychiatric disease
Guilarte, T. R., Hammoud, D. A., McGlothan, J. L., Caffo, B. S., Foss, C. A., Kozikowski, A. P., & Pomper, M. G. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.013 · Cited by 46
Targeting astrocytes in bipolar disorder
Peng, L., Li, B., & Verkhratsky, A. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1171144 · Cited by 46
Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims
Rafało-Ulińska, A., Piotrowska, J., Kryczyk‐Poprawa, A., Opoka, W., Sowa-Kućma, M., Misztak, P., Rajkowska, G., Stockmeier, C. A., Datka, W., Nowak, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.008 · Cited by 45
de Bartolomeis, A., Buonaguro, E. F., Iasevoli, F., & Tomasetti, C. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114523864 · Cited by 44
Micheau, J., Vimeney, A., Normand, E., Mulle, C., & Riedel, G. (2014) · Hippocampus · doi:10.1002/hipo.22290 · Cited by 43
Basselin, M., Ramadan, E., & Rapoport, S. I. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.12.001 · Cited by 43
Expression of Transcripts for Myelin Related Genes in Postmortem Brain from Cocaine Abusers
Kristiansen, L. V., Bannon, M. J., & Meador‐Woodruff, J. H. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9655-3 · Cited by 43
Self-citationSun, Y., Cheng, X., Zhang, L., Hu, J. H., chen, Y., Zhan, L., & Gao, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9715-7 · Cited by 43
Tsunoka, T., Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Okumura, T., Inada, T., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.04.007 · Cited by 43
Moore, H. M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq106 · Cited by 43
Wijtenburg, S. A., Wang, M., Korenic, S. A., Chen, S., Barker, P. B., & Rowland, L. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.656459 · Cited by 42
Kovačević, T., Skelin, I., Minuzzi, L., Rosa-Neto, P., & Diksic, M. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.01.010 · Cited by 41
“Also AMPA (GluR1, GluR3), kainate (GluR5), and NMDA (NR2B) were decreased in the perirhinal cortex of the patients with major depression [5], and decreased glutamate and glutamine levels in the frontal cortex of patients with depression were reported [3].”
BackgroundGibbons, A. S., Brooks, L., Scarr, E., & Dean, B. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.001 · Cited by 41
Limbic changes identified by imaging in bipolar patients
Brambilla, P., Hatch, J. P., & Soares, J. C. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0080-8 · Cited by 41
Lee, H., Rao, J. S., Rapoport, S. I., & Bazinet, R. P. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.018 · Cited by 41
Regulation of kainate receptor subunit mRNA by stress and corticosteroids in the rat hippocampus
Hunter, R. G., Bellani, R., Bloss, E., Costa, A., McCarthy, K., & McEwen, B. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004328 · Cited by 40
“KA1, GluR5 and GluR6 have also shown association with schizophrenia and bipolar disorder [9,10].”
BackgroundAntidepressant-Like Effects of CX717, a Positive Allosteric Modulator of AMPA Receptors
Gordillo-Salas, M., Pascual-Antón, R., Ren, J. T., Greer, J. J., & Adell, A. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01954-x · Cited by 40
Shared impairment in associative learning in schizophrenia and bipolar disorder
Brambilla, P., Cerruti, S., Bellani, M., Perlini, C., Ferro, A., Marinelli, V., Giusto, D., Tomelleri, L., Rambaldelli, G., Tansella, M., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.007 · Cited by 40
McOmish, C. E., Pavey, G., Gibbons, A. S., Hopper, S., Udawela, M., Scarr, E., & Dean, B. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.004 · Cited by 40
Scotti-Muzzi, E., Chile, T., Moreno, R. A., Pastorello, B., Leite, C. D. C., Henning, A., Otaduy, M. C. G., Vallada, H., & Soeiro‐de‐Souza, M. G. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01096-0 · Cited by 39
Cannabidiol modulation of hippocampal glutamate in early psychosis
O’Neill, A., Annibale, L., Blest‐Hopley, G., Wilson, R. P., Giampietro, V., & Bhattacharyya, S. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211001107 · Cited by 38
Caballero, J. L., Pacchiarotti, I., Murru, A., Valentí, M., Colom, F., Benach, B., Pérez, V., Dalmau, J. O., & Vieta, E. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.012 · Cited by 38
A conceptualized model linking matrix metalloproteinase-9 to schizophrenia pathogenesis
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.015 · Cited by 38
Gruenbaum, B. F., Zlotnik, A. A., Frenkel, A., Fleidervish, I. A., & Boyko, M. (2022) · Metabolites · doi:10.3390/metabo12050459 · Cited by 37
Teyssier, J., Ragot, S., Chauvet‐Gélinier, J., Trojak, B., & Bonin, B. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.021 · Cited by 37
Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder
Kerner, B., Jasinska, A. J., DeYoung, J. A., Almonte, M., Choi, O., & Freimer, N. B. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30780 · Cited by 37
GABA Transporter-1 Deficiency Confers Schizophrenia-Like Behavioral Phenotypes
Yu, Z., Fang, Q., Xiao, X., Wang, Y., Cai, Y.-Q., Cao, H., Hu, G., Chen, Z., Fei, J., Gong, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069883 · Cited by 36
Amidfar, M., Réus, G. Z., Quevedo, J., Kim, Y., & Arbabi, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.11.003 · Cited by 36
Behavioral and Molecular Biomarkers in Translational Animal Models for Neuropsychiatric Disorders
Sarnyai, Z., Alsaif, M., Bahn, S., Ernst, A., Guest, P. C., Hradetzky, E., Kluge, W., Stelzhammer, V., & Wesseling, H. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00008-0 · Cited by 36
Memantine reduces mania-like symptoms in animal models
Gao, Y., Payne, R. S., Schurr, A., Hougland, M. T., Lord, J., Herman, L., Lei, Z. M., Banerjee, P., & El‐Mallakh, R. S. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.030 · Cited by 36
Wang, M.-J., Li, Y., Snyder, M. A., Wang, H., Li, F., & Gao, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061787 · Cited by 37
Bellia, F., Vismara, M. E. M., Annunzi, E., Cifani, C., Benatti, B., Dell’Osso, B. M., & D’Addario, C. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.10.040 · Cited by 35
Kainate receptors in the developing neuronal networks
Lauri, S. E., Ryazantseva, M., Orav, E., Vesikansa, A., & Taira, T. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108585 · Cited by 35
Molecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update
Govindula, A., Pai, A., Baghel, S. S., & Mudgal, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174364 · Cited by 35
Amat-Foraster, M., Jensen, A. A., Plath, N., Herrik, K. F., Celada, P., & Artigas, F. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.022 · Cited by 36
Molecular alterations in the medial temporal lobe in schizophrenia
Bobilev, A. M., Perez, J. M., & Tamminga, C. A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.001 · Cited by 35
Dean, B. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612805289935 · Cited by 34
Bai, L., Hou, Y., Zhu, M., Bao, H., Nie, J., Zhang, G. Y., Shan, L., Yao, Y., Du, K., Yang, H., et al. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv112 · Cited by 34
Li, B., Zhang, S., Li, M., Zhang, H., Hertz, L., & Peng, L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.004 · Cited by 33
“This finding may, however, suggest that the decreased GluK2 receptor density reported by Beneyto et al. (2007) and Benes et al. (2007) in bipolar patients could have been a result of the medication these patients had received.”
InfluentialMancini, V., Saleh, M. G., Delavari, F., Bagautdinova, J., & Eliez, S. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.03.021 · Cited by 33
Luykx, J. J., Boks, M. P., Terwindt, A. P. R., Bakker, S. C., Kahn, R. S., & Ophoff, R. A. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.008 · Cited by 33
Dong, L., Li, B., Verkhratsky, A., & Peng, L. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3921-2 · Cited by 32
André, J. M., Leach, P. T., & Gould, T. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.004 · Cited by 32
Cole, J., Selby, B., Ismail, Z., & McGirr, A. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.04.002 · Cited by 32
Tse, Y. C., Lopez, J., Moquin, A., Wong, S.-M. A., Maysinger, D., & Wong, T. P. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0325-8 · Cited by 32
Okada, M., Kawano, Y., Fukuyama, K., Motomura, E., & Shiroyama, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217951 · Cited by 32
Halaris, A. E., & Cook, J. T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_21 · Cited by 33
Putkonen, N., Kukkonen, J. P., Mudò, G., Putula, J., Belluardo, N., Lindholm, D., & Korhonen, L. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07858.x · Cited by 32
Neurotransmitters and neuropeptides in depression
Bao, A., Ruhé, H. G., Gao, S., & Swaab, D. F. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00008-5 · Cited by 36
Bao, H., Sun, L., Zhu, Y., Ran, P., Hu, W., Zhu, K., Bai, L., Hou, Y., Nie, J., Gao, T., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.062 · Cited by 32
Cao, Y. J., Wang, Q., Xing, Z., Cheng, Y., & Zhang, Y. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.053 · Cited by 32
Sabbagh, J. J., Murtishaw, A. S., Bolton, M. M., Heaney, C. F., Langhardt, M. A., & Kinney, J. W. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.040 · Cited by 32
Burt, M. A., Tse, Y. C., Boksa, P., & Wong, T. P. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000229 · Cited by 31
Sales, A. J., Maciel, I. D. S., Suavinha, A. C. D. R., & Joca, S. R. L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02145-4 · Cited by 31
Schizophrenia: Redox Regulation and Volume Neurotransmission
Bókkon, I., & Antal, I. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596504 · Cited by 32
Metadata
- Authors
- Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H.
- Affiliations
- University of Alabama at Birmingham (US)
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-14
- Volume
- 32
- Issue
- 9
- Pages
- 1888-1902
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2024278554
- Cited by
- 408
- References
- 115
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 12 · 2023: 15 · 2022: 32 · 2021: 26 · 2020: 22 · 2019: 19 · 2018: 10 · 2017: 13 · 2016: 18 · 2015: 32 · 2014: 23 · 2013: 25 · 2012: 28
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stanley Medical Research Institute
- National Institute of Mental Health (MH 53327, R01MH053327)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- glutamate receptors, schizophrenia, bipolar disorder, major depressive disorder, mood disorders, medial temporal lobe, entorhinal cortex, perirhinal cortex, hippocampus, NMDA receptor, AMPA receptors, kainate receptors, receptor binding, glutamatergic neurotransmission, synaptic transmission
- MeSH terms
- Adult, Analysis of Variance, Autoradiography, Female, Gene Expression Regulation, Humans, Indoles, Male, Middle Aged, Postmortem Changes, Protein Binding, Schizophrenia, Temporal Lobe, 2-Amino-5-phosphonovalerate, In Situ Hybridization, Receptors, Glutamate, Excitatory Amino Acid Antagonists, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.